Text Resize

Researchers reject antioxidant/statin drug study

Shortly after we sent you the last eAlert on the recent study that suggests some antioxidants may inhibit statin drugs, HSI panelist Randall Wilkinson, M.D. faxed us an article from Science News magazine critiquing the study. Apparently, not all conventional cardiovascular researchers agree with the conclusions of the Journal of the American Heart Association (JAHA). Dr. Ishwarial Jialal, a researcher at the University of Texas Southwestern Medical Center, noted that in his extensive work in the area, he has never had a problem coupling statin drugs with antioxidants. Further, he conferred with researchers at the University of Oxford in England and found their experiences match his. Dr. Jialal theorizes that the inhibitive effect was probably caused by an interaction between the antioxidants with niacin, which was given along with the statin medication (as is common practice) in the JAHA study.

  |   Back to top   |  

Recent Articles:

Load More Articles
Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >